» Articles » PMID: 1513096

Glomerular Structure in Type-1 (insulin-dependent) Diabetic Patients with Normo- and Microalbuminuria

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1992 Apr 1
PMID 1513096
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney biopsies from 15 type-1 (insulin-dependent) diabetic patients with a range of albumin excretion (AER) were analyzed. Nine patients had normal AER, and six had microalbuminuria. Basement membrane thickness, BMT, and mesangial matrix volume fraction, Vv(mat/glom), were obtained from at least three glomeruli per biopsy. Mesangial structures were estimated with electron microscopic analysis at three levels in each glomerulus. Glomerulopathy parameters were significantly increased in micro- versus normoalbuminuric patients with the following means and (CV): BMT 571 nm (0.12) and 442 nm (0.25), P = 0.03; Vv(mes/glom) 0.31 (0.20) and 0.22 (0.14), P = 0.002; Vv(matrix/glom) 0.17 (0.25) and 0.11 (0.28), P = 0.006; matrix star volume 56 microns 3 (0.47) and 22 microns 3 (0.43), P = 0.02. A positive correlation obtained between AER and each of the glomerulopathy parameters, BM thickness, Vv(mes/glom) and Vv(matrix/glom), as well as between AER and a structural index expressing the sum of changes in the peripheral BM and in the mesangium (r = 0.62, P = 0.01). The results indicated a parallel course of mesangial and peripheral BM changes: a positive correlation obtained between BM thickness and mesangial parameters [BMT versus Vv(matrix/glom): r = 0.82, P = 0.0001] and the ratio of the two subsets of glomerular BM material (PBM:matrix) did not show significant difference between normo- and microalbuminuric groups. The data give strong support to the contention that the transition from normo- into the microalbuminuric phase is linked to progressing glomerulopathy.

Citing Articles

Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency.

Deng L, Li W, Xu G Eur J Med Res. 2021; 26(1):144.

PMID: 34895352 PMC: 8665546. DOI: 10.1186/s40001-021-00612-9.


Update on blood pressure control and renal outcomes in diabetes mellitus.

Joven M, Anderson R Curr Diab Rep. 2015; 15(7):44.

PMID: 25990743 DOI: 10.1007/s11892-015-0613-6.


The natural progression of kidney injury in young type 1 diabetic patients.

Steinke J Curr Diab Rep. 2009; 9(6):473-9.

PMID: 19954694 DOI: 10.1007/s11892-009-0077-7.


The effects of candesartan on diabetes glomerulopathy: a double-blind, placebo-controlled trial.

Perrin N, Jaremko G, Berg U Pediatr Nephrol. 2008; 23(6):947-54.

PMID: 18270751 DOI: 10.1007/s00467-008-0745-x.


Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant?.

White K, Marshall S, Bilous R Diabetologia. 2007; 50(5):906-12.

PMID: 17333103 DOI: 10.1007/s00125-007-0624-1.